Agilent Technologies, Inc. (NYSE:A) Shares Acquired by BSW Wealth Partners

BSW Wealth Partners lifted its holdings in Agilent Technologies, Inc. (NYSE:A) by 8.2% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 5,343 shares of the medical research company’s stock after purchasing an additional 403 shares during the quarter. BSW Wealth Partners’ holdings in Agilent Technologies were worth $718,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also modified their holdings of A. Public Sector Pension Investment Board lifted its stake in shares of Agilent Technologies by 73.6% in the 2nd quarter. Public Sector Pension Investment Board now owns 11,272 shares of the medical research company’s stock worth $1,461,000 after acquiring an additional 4,779 shares during the period. Creative Planning boosted its stake in Agilent Technologies by 0.3% during the 2nd quarter. Creative Planning now owns 42,412 shares of the medical research company’s stock valued at $5,498,000 after purchasing an additional 118 shares in the last quarter. NewEdge Advisors LLC increased its position in shares of Agilent Technologies by 17.9% during the 2nd quarter. NewEdge Advisors LLC now owns 18,347 shares of the medical research company’s stock valued at $2,378,000 after purchasing an additional 2,782 shares during the period. Northwestern Mutual Wealth Management Co. raised its stake in shares of Agilent Technologies by 14.7% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 2,858 shares of the medical research company’s stock worth $370,000 after buying an additional 366 shares in the last quarter. Finally, EP Wealth Advisors LLC lifted its holdings in shares of Agilent Technologies by 20.0% in the second quarter. EP Wealth Advisors LLC now owns 9,616 shares of the medical research company’s stock valued at $1,247,000 after buying an additional 1,601 shares during the period.

Insiders Place Their Bets

In other news, CEO Padraig Mcdonnell sold 1,911 shares of Agilent Technologies stock in a transaction dated Tuesday, January 21st. The shares were sold at an average price of $150.00, for a total transaction of $286,650.00. Following the sale, the chief executive officer now directly owns 39,652 shares in the company, valued at approximately $5,947,800. The trade was a 4.60 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on A shares. Barclays dropped their price target on shares of Agilent Technologies from $145.00 to $135.00 and set an “underweight” rating on the stock in a research report on Wednesday, November 27th. Bank of America decreased their price target on shares of Agilent Technologies from $153.00 to $150.00 and set a “neutral” rating on the stock in a research report on Friday, December 13th. Wells Fargo & Company reduced their price objective on Agilent Technologies from $157.00 to $155.00 and set an “overweight” rating for the company in a research note on Monday, December 9th. StockNews.com raised Agilent Technologies from a “hold” rating to a “buy” rating in a research report on Tuesday, December 24th. Finally, JPMorgan Chase & Co. dropped their price target on Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating on the stock in a research note on Tuesday, November 26th. One analyst has rated the stock with a sell rating, six have given a hold rating and eight have issued a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $143.62.

Agilent Technologies Trading Down 0.4 %

NYSE:A opened at $150.35 on Wednesday. The company has a quick ratio of 1.58, a current ratio of 2.09 and a debt-to-equity ratio of 0.57. The company’s 50 day moving average is $138.91 and its 200-day moving average is $138.37. The firm has a market cap of $42.94 billion, a price-to-earnings ratio of 34.02, a P/E/G ratio of 4.12 and a beta of 1.06. Agilent Technologies, Inc. has a 12 month low of $124.16 and a 12 month high of $155.35.

Agilent Technologies (NYSE:A) last released its quarterly earnings results on Monday, November 25th. The medical research company reported $1.46 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.41 by $0.05. Agilent Technologies had a net margin of 19.80% and a return on equity of 25.43%. The company had revenue of $1.70 billion during the quarter, compared to analysts’ expectations of $1.67 billion. During the same period in the prior year, the company earned $1.38 earnings per share. The business’s quarterly revenue was up .8% compared to the same quarter last year. Equities analysts anticipate that Agilent Technologies, Inc. will post 5.56 EPS for the current year.

Agilent Technologies Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, January 22nd. Investors of record on Tuesday, December 31st were paid a dividend of $0.248 per share. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.24. This represents a $0.99 annualized dividend and a yield of 0.66%. The ex-dividend date was Tuesday, December 31st. Agilent Technologies’s dividend payout ratio is presently 22.40%.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.